We are live on ! Find out more
SK

Seth Klarman Baupost Group

AUM $5.42B
1-Year Est. Return 22.93%
 

Seth Klarman is the founder and CEO of the Baupost Group, one of the most respected value-oriented investment firms. He is the author of Margin of Safety and is known for patient, opportunistic capital allocation across equities, credit, and special situations. Klarman’s approach emphasizes downside protection, cash when opportunities are scarce, and independent thinking when markets become crowded.

This Fund
S&P 500
This Quarter Est. Return
+2.69%
1 Year Est. Return
+22.93%
3 Year Est. Return
+47.86%
5 Year Est. Return
+25.7%
10 Year Est. Return
+163.46%
AUM
$11B
AUM Growth
-$854M
Cap. Flow
-$1.24B
Cap. Flow %
-11.22%
Top 10 Hldgs %
70.17%
Holding
36
New
1
Increased
8
Reduced
9
Closed
4

Top Buys

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$419M
2
XPO icon
XPO
XPO
+$88.3M
3
LBTYK icon
Liberty Global Class C
LBTYK
+$73.1M
4
PARA
Paramount Global Class B
PARA
+$72.2M
5
LBTYA icon
Liberty Global Class A
LBTYA
+$65.5M

Top Sells

Rank Stock Value
1
CELG
Celgene Corp
CELG
+$377M
2
PXD
Pioneer Natural Resource Co.
PXD
+$305M
3
EBAY icon
eBay
EBAY
+$193M
4
SYF icon
Synchrony
SYF
+$169M
5
AGN
Allergan plc
AGN
+$151M

Sector Composition

Rank Sector Weight
1 Communication Services 28.89%
2 Healthcare 22.34%
3 Technology 15.28%
4 Consumer Discretionary 8.63%
5 Energy 8.04%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
VRTV
26
DELISTED
VERITIV CORPORATION
VRTV
$69.2M 0.63%
3,564,439
– –
TMQ
27
Trilogy Metals
TMQ
$684M
$39.8M 0.36%
13,641,368
+590,610
+5% +$1.56M
SBGI icon
28
Sinclair Inc
SBGI
$1.04B
$29.5M 0.27%
549,423
-2,358,673
-81% -$120M
GOSS icon
29
Gossamer Bio
GOSS
$75.6M
$27.3M 0.25%
1,267,171
– –
PRTK
30
DELISTED
Paratek Pharmaceuticals, Inc.
PRTK
$9.55M 0.09%
2,394,498
– –
DIS icon
31
Walt Disney
DIS
$186B
– –
-399,151
Closed -$44.3M
PXD
32
DELISTED
Pioneer Natural Resource Co.
PXD
– –
-2,001,814
Closed -$305M
GTYHW
33
DELISTED
GTY Technology Holdings, Inc. Warrants
GTYHW
– –
-1,466,666
Closed -$884K
CELG
34
DELISTED
Celgene Corp
CELG
– –
-4,000,000
Closed -$377M
1
2

Similar funds

SNT
SIG North Trading Bala Cynwyd, Pennsylvania $5.42B AUM 31.03% 1-Year Est. Return
MYIA
Mount Yale Investment Advisors Denver, Colorado $5.4B AUM 28.46% 1-Year Est. Return
O
OrbiMed New York $5.4B AUM 163.13% 1-Year Est. Return
RC
Resolution Capital Sydney, NSW, Australia $5.44B AUM 27.71% 1-Year Est. Return
SCM
Shelton Capital Management Denver, Colorado $5.39B AUM 56.42% 1-Year Est. Return
AC
AlphaCore Capital La Jolla, California $5.44B AUM 26.35% 1-Year Est. Return
TPCW
TD Private Client Wealth New York $5.44B AUM 18.56% 1-Year Est. Return
BJL
Brighton Jones LLC Seattle, Washington $5.38B AUM 27.31% 1-Year Est. Return

Seth Klarman's Q2 2019 Portfolio in Review

As of Q2 2019, Seth Klarman held 36 positions worth $11B, down 7.2% from $11.9B the previous quarter. Its ten largest holdings account for 70% of the portfolio.

Seth Klarman withdrew a net $1.24B in Q2 2019, closing 4 positions and reducing 9 holdings. Its most notable exit was Celgene Corp, an estimated $377M position sold in full.

By sector, the portfolio is most concentrated in Communication Services at 29% of assets, up from 25% a quarter earlier, followed by Healthcare and Technology.

Against the trend, Seth Klarman opened a new position in XPO worth $86.7M.

  • Seth Klarman's largest Q2 2019 buy was XPO: 4,337,091 shares worth $86.7M.
  • Seth Klarman added most to Bristol-Myers Squibb in Q2 2019, an estimated $419M increase.
  • Seth Klarman's biggest Q2 2019 reduction was eBay, cutting an estimated $193M.
  • Seth Klarman fully exited Celgene Corp in Q2 2019, selling an estimated $377M.
  • Seth Klarman's ten largest holdings make up 70% of its $11B portfolio in Q2 2019.
  • Seth Klarman opened 1 new position and closed 4 in Q2 2019.
  • Seth Klarman's portfolio value fell 7.2% quarter-over-quarter to $11B.

Based on Baupost Group's 13F filing for Q2 2019, filed 13 Aug 2019.